Early research (Phase 1)Ended earlyNCT00968097
What this trial is testing
Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition
Who this might be right for
Alzheimer's Disease
Institute for Neurodegenerative Disorders 12